By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Clontech Laboratories and Tet Systems said today they have expanded an existing licensing agreement to grant Clontech rights to develop, manufacture, and commercialize novel Tet products, including the Tet-On 3G Inducible Expression System.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.